Example: Heart Attack

Clinical Trials on Histiocytoma, Malignant Fibrous

Total 80 results

NCT04123535

Recruiting

Focused Ultrasound to Promote Immune Responses for Undifferentiated Pleomorphic Sarcoma

Conditions: Undifferentiated Pleomorphic Sarcoma
NCT03946943

Not yet recruiting

Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma

Conditions: Soft Tissue Sarcomas; Undifferentiated Pleomorphic Sarcoma
NCT04480502

Recruiting

ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma

Conditions: Undifferentiated Pleomorphic Sarcoma; Myxofibrosarcoma
NCT03307616

Active, not recruiting

Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery

Conditions: Dedifferentiated Liposarcoma; Recurrent Dedifferentiated Liposarcoma; Recurrent Undifferentiated Pleomorphic Sarcoma; Resectable Dedifferentiated Liposarcoma; Resectable Undifferentiated Pleomorphic Sarcoma; Undifferentiated Pleomorphic Sarcoma
NCT03123276

Recruiting

Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma

Conditions: Sarcoma
NCT00450736

Completed

Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery

Conditions: Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma
NCT00334854

Unknown status

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

Conditions: Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma
NCT00667342

Completed

A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma

Conditions: Osteosarcoma; Malignant Fibrous Histiocytoma (MFH) of Bone
NCT00334984

Withdrawn

Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma

Conditions: Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma
NCT00002898

Completed

Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma

Conditions: Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma
NCT00031915

Completed

Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma

Conditions: Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma
NCT00007046

Completed

Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone

Conditions: Stenosis; Histiocytoma
NCT04332874

Recruiting

A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg

Conditions: Sarcoma; Myxofibrosarcoma; Undifferentiated Pleomorphic Sarcoma; Alveolar Soft Part Sarcoma
NCT03899805

Recruiting

A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas

Conditions: Sarcoma; Liposarcoma; Leiomyosarcoma; Undifferentiated Pleomorphic Sarcoma
NCT02565758

Completed

ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors

Conditions: Advanced Solid Tumors; Undifferentiated Pleomorphic Sarcoma; Squamous Cell Carcinoma of the Head and Neck; Carcinoma of the Breast
NCT00400569

Completed

Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma

Conditions: Liposarcoma; Leiomyosarcoma; Fibrosarcoma; Malignant Fibrous Histiocytoma
NCT04242238

Recruiting

Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas

Conditions: Sarcoma; Advanced Sarcoma; High Grade Sarcoma; Leiomyosarcoma; Undifferentiated Pleomorphic Sarcoma; Myxofibrosarcoma; Dedifferentiated Liposarcoma
NCT03759327

Completed

Angiomatoid Fibrous Histiocytoma: a Single Institution Case-series

Conditions: Angiomatoid Fibrous Histiocytoma
NCT04447274

Not yet recruiting

A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS

Conditions: Sarcoma
NCT04356872

Recruiting

The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma

Conditions: Sarcoma, Soft Tissue
NCT02923778

Recruiting

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

Conditions: FNCLCC Sarcoma Grade 2; FNCLCC Sarcoma Grade 3; Leiomyosarcoma; Resectable Leiomyosarcoma; Resectable Liposarcoma; Resectable Soft Tissue Sarcoma; Resectable Undifferentiated Pleomorphic Sarcoma; Stage I Soft Tissue Sarcoma AJCC v7; Stage IA Soft Tissue Sarcoma AJCC v7; Stage IB Soft Tissue Sarcoma AJCC v7; Stage II Soft Tissue Sarcoma AJCC v7; Stage IIA Soft Tissue Sarcoma AJCC v7; Stage IIB Soft Tissue Sarcoma AJCC v7
NCT01418001

Terminated

Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)

Conditions: Sarcoma; Leiomyosarcoma; Malignant Peripheral Nerve Sheath Tumor; Malignant Fibrous; Histiocytoma/Undifferentiated Pleomorphic Sarcoma
NCT00474994

Completed

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

Conditions: Adult Malignant Fibrous Histiocytoma of Bone; Desmoid Tumor; Endometrial Cancer; Ovarian Cancer; Sarcoma; Small Intestine Cancer
NCT04420975

Recruiting

Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma

Conditions: Leiomyosarcoma; Myxofibrosarcoma; Resectable Dedifferentiated Liposarcoma; Resectable Soft Tissue Sarcoma; Resectable Undifferentiated Pleomorphic Sarcoma; Soft Tissue Fibrosarcoma; Spindle Cell Sarcoma; Stage I Retroperitoneal Sarcoma American Joint Committee on Cancer (AJCC) v8; Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IA Retroperitoneal Sarcoma AJCC v8; Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IB Retroperitoneal Sarcoma AJCC v8; Stage IB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage II Retroperitoneal Sarcoma AJCC v8; Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Storiform-Pleomorphic Malignant Fibrous Histiocytoma; Synovial Sarcoma; Undifferentiated Pleomorphic Sarcoma With Osteoclast-Like Giant Cells; Undifferentiated Pleomorphic Sarcoma, Inflammatory Variant
NCT04008238

Recruiting

Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients

Conditions: Soft Tissue Sarcoma Adult; Undifferentiated Pleomorphic Sarcoma; Epithelioid Sarcoma; Solitary Fibrous Tumors; Hemangioendothelioma; Desmoplastic Round Cell Tumor; Synovial Sarcoma